We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months

News   Sep 25, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
New CAR T-Cell Therapy for Blood Cancer Relapse Patients Could Be in Clinical Trials Within Six Months
 
 
Advertisement
 

RELATED ARTICLES

CRISPR Made More Precise by New Algorithm

News

Researchers from have developed a new method that makes CRISPR gene editing more precise than conventional methods. The method selects the molecules best suited for helping the CRISPR-Cas9 protein with high-precision editing at the correct location in our DNA, the researchers explain.

READ MORE

Human Cells Can Convert RNA Sequences Into DNA

News

Researchers have provided evidence that RNA segments can be written back into DNA, which potentially challenges the central dogma in biology and could have wide implications in biology.

READ MORE

Ovarian Cancer Treatment Proves Effective in Preclinical Model

News

Preclinical trials of Pb-214-labeled Trastuzumab, a new ovarian cancer treatment, have produced successful results, dramatically limiting tumor growth and decreasing tumor mass.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE